Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML

NCT01161550 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG: Granulocyte colony-stimulating factor (G-CSF)
DRUG: Cladribine
DRUG: Cytarabine
DRUG: All-Trans Retinoic Acid (ATRA)
DRUG: Midostaurin

Sponsor

Washington University School of Medicine